drugset / Trial / NCT06114979
Silodosin vs Placebo in the Treatment of Female LUTS
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This trial will be conducted to study the efficacy and safety of Silodosin in the treatment of female lower urinary tract symptoms.
Timeline
- Start
- 2023-11-01
- Primary completion
- 2024-10-30
- Completion
- 2024-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Silodosin | Unknown | 8 mg | — |
Indications
No indication recorded.